 | • レポートコード：MRC2Q12-19326 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ペチジン塩酸塩のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ペチジン塩酸塩のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ペチジン塩酸塩の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ペチジン塩酸塩のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのペチジン塩酸塩の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のペチジン塩酸塩の売上および2028年までの予測に焦点を当てています。 ペチジン塩酸塩のグローバル主要企業には、Purdue Pharma、Egalet、Boehringer Ingelheim、Janssen、Sanofi、Sun Pharmaceuticals、Mallinckrodt Pharmaceuticals、Endo Pharmaceuticals、Actavis、Pfizer、Simson Pharma Limited、Taj Pharmaceuticals、PipelinePharma、Exir Pharmaceutical Companyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ペチジン塩酸塩市場は、タイプとアプリケーションによって区分されます。世界のペチジン塩酸塩市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 粉末、液体 【アプリケーション別セグメント】 病院、クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ペチジン塩酸塩製品概要 - タイプ別市場（粉末、液体） - アプリケーション別市場（病院、クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界のペチジン塩酸塩販売量予測2017-2028 - 世界のペチジン塩酸塩売上予測2017-2028 - ペチジン塩酸塩の地域別販売量 - ペチジン塩酸塩の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ペチジン塩酸塩販売量 - 主要メーカー別ペチジン塩酸塩売上 - 主要メーカー別ペチジン塩酸塩価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（粉末、液体） - ペチジン塩酸塩のタイプ別販売量 - ペチジン塩酸塩のタイプ別売上 - ペチジン塩酸塩のタイプ別価格 ・アプリケーション別市場規模（病院、クリニック） - ペチジン塩酸塩のアプリケーション別販売量 - ペチジン塩酸塩のアプリケーション別売上 - ペチジン塩酸塩のアプリケーション別価格 ・北米市場 - 北米のペチジン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別のペチジン塩酸塩市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのペチジン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別のペチジン塩酸塩市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のペチジン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別のペチジン塩酸塩市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のペチジン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別のペチジン塩酸塩市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのペチジン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別のペチジン塩酸塩市場規模（トルコ、サウジアラビア） ・企業情報 Purdue Pharma、Egalet、Boehringer Ingelheim、Janssen、Sanofi、Sun Pharmaceuticals、Mallinckrodt Pharmaceuticals、Endo Pharmaceuticals、Actavis、Pfizer、Simson Pharma Limited、Taj Pharmaceuticals、PipelinePharma、Exir Pharmaceutical Company ・産業チェーン及び販売チャネル分析 - ペチジン塩酸塩の産業チェーン分析 - ペチジン塩酸塩の原材料 - ペチジン塩酸塩の生産プロセス - ペチジン塩酸塩の販売及びマーケティング - ペチジン塩酸塩の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ペチジン塩酸塩の産業動向 - ペチジン塩酸塩のマーケットドライバー - ペチジン塩酸塩の課題 - ペチジン塩酸塩の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Pethidine Hydrochloride is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Pethidine Hydrochloride is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Pethidine Hydrochloride is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Pethidine Hydrochloride include Purdue Pharma, Egalet, Boehringer Ingelheim, Janssen, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals and Actavis, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pethidine Hydrochloride manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Pethidine Hydrochloride market. Further, it explains the major drivers and regional dynamics of the global Pethidine Hydrochloride market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer
Simson Pharma Limited
Taj Pharmaceuticals
PipelinePharma
Exir Pharmaceutical Company
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Pethidine Hydrochloride Segment by Type
Powder
Liquid
Pethidine Hydrochloride Segment by Application
Hospital
Clinic
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pethidine Hydrochloride market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Pethidine Hydrochloride, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Pethidine Hydrochloride, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pethidine Hydrochloride, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pethidine Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Pethidine Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Pethidine Hydrochloride sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Purdue Pharma, Egalet, Boehringer Ingelheim, Janssen, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals and Actavis, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pethidine Hydrochloride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pethidine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pethidine Hydrochloride sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Pethidine Hydrochloride Product Introduction
1.2 Market by Type
1.2.1 Global Pethidine Hydrochloride Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Powder
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Pethidine Hydrochloride Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pethidine Hydrochloride Sales Estimates and Forecasts 2017-2028
2.2 Global Pethidine Hydrochloride Revenue Estimates and Forecasts 2017-2028
2.3 Global Pethidine Hydrochloride Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pethidine Hydrochloride Sales by Region
2.4.1 Global Pethidine Hydrochloride Sales by Region (2017-2022)
2.4.2 Global Sales Pethidine Hydrochloride by Region (2023-2028)
2.5 Global Pethidine Hydrochloride Revenue by Region
2.5.1 Global Pethidine Hydrochloride Revenue by Region (2017-2022)
2.5.2 Global Pethidine Hydrochloride Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pethidine Hydrochloride Sales by Manufacturers
3.1.1 Global Top Pethidine Hydrochloride Manufacturers by Sales (2017-2022)
3.1.2 Global Pethidine Hydrochloride Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pethidine Hydrochloride in 2021
3.2 Global Pethidine Hydrochloride Revenue by Manufacturers
3.2.1 Global Pethidine Hydrochloride Revenue by Manufacturers (2017-2022)
3.2.2 Global Pethidine Hydrochloride Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pethidine Hydrochloride Revenue in 2021
3.3 Global Pethidine Hydrochloride Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pethidine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pethidine Hydrochloride Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pethidine Hydrochloride Sales by Type
4.1.1 Global Pethidine Hydrochloride Historical Sales by Type (2017-2022)
4.1.2 Global Pethidine Hydrochloride Forecasted Sales by Type (2023-2028)
4.1.3 Global Pethidine Hydrochloride Sales Market Share by Type (2017-2028)
4.2 Global Pethidine Hydrochloride Revenue by Type
4.2.1 Global Pethidine Hydrochloride Historical Revenue by Type (2017-2022)
4.2.2 Global Pethidine Hydrochloride Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pethidine Hydrochloride Revenue Market Share by Type (2017-2028)
4.3 Global Pethidine Hydrochloride Price by Type
4.3.1 Global Pethidine Hydrochloride Price by Type (2017-2022)
4.3.2 Global Pethidine Hydrochloride Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pethidine Hydrochloride Sales by Application
5.1.1 Global Pethidine Hydrochloride Historical Sales by Application (2017-2022)
5.1.2 Global Pethidine Hydrochloride Forecasted Sales by Application (2023-2028)
5.1.3 Global Pethidine Hydrochloride Sales Market Share by Application (2017-2028)
5.2 Global Pethidine Hydrochloride Revenue by Application
5.2.1 Global Pethidine Hydrochloride Historical Revenue by Application (2017-2022)
5.2.2 Global Pethidine Hydrochloride Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pethidine Hydrochloride Revenue Market Share by Application (2017-2028)
5.3 Global Pethidine Hydrochloride Price by Application
5.3.1 Global Pethidine Hydrochloride Price by Application (2017-2022)
5.3.2 Global Pethidine Hydrochloride Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pethidine Hydrochloride Market Size by Type
6.1.1 North America Pethidine Hydrochloride Sales by Type (2017-2028)
6.1.2 North America Pethidine Hydrochloride Revenue by Type (2017-2028)
6.2 North America Pethidine Hydrochloride Market Size by Application
6.2.1 North America Pethidine Hydrochloride Sales by Application (2017-2028)
6.2.2 North America Pethidine Hydrochloride Revenue by Application (2017-2028)
6.3 North America Pethidine Hydrochloride Market Size by Country
6.3.1 North America Pethidine Hydrochloride Sales by Country (2017-2028)
6.3.2 North America Pethidine Hydrochloride Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pethidine Hydrochloride Market Size by Type
7.1.1 Europe Pethidine Hydrochloride Sales by Type (2017-2028)
7.1.2 Europe Pethidine Hydrochloride Revenue by Type (2017-2028)
7.2 Europe Pethidine Hydrochloride Market Size by Application
7.2.1 Europe Pethidine Hydrochloride Sales by Application (2017-2028)
7.2.2 Europe Pethidine Hydrochloride Revenue by Application (2017-2028)
7.3 Europe Pethidine Hydrochloride Market Size by Country
7.3.1 Europe Pethidine Hydrochloride Sales by Country (2017-2028)
7.3.2 Europe Pethidine Hydrochloride Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pethidine Hydrochloride Market Size by Type
8.1.1 Asia Pacific Pethidine Hydrochloride Sales by Type (2017-2028)
8.1.2 Asia Pacific Pethidine Hydrochloride Revenue by Type (2017-2028)
8.2 Asia Pacific Pethidine Hydrochloride Market Size by Application
8.2.1 Asia Pacific Pethidine Hydrochloride Sales by Application (2017-2028)
8.2.2 Asia Pacific Pethidine Hydrochloride Revenue by Application (2017-2028)
8.3 Asia Pacific Pethidine Hydrochloride Market Size by Region
8.3.1 Asia Pacific Pethidine Hydrochloride Sales by Region (2017-2028)
8.3.2 Asia Pacific Pethidine Hydrochloride Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pethidine Hydrochloride Market Size by Type
9.1.1 Latin America Pethidine Hydrochloride Sales by Type (2017-2028)
9.1.2 Latin America Pethidine Hydrochloride Revenue by Type (2017-2028)
9.2 Latin America Pethidine Hydrochloride Market Size by Application
9.2.1 Latin America Pethidine Hydrochloride Sales by Application (2017-2028)
9.2.2 Latin America Pethidine Hydrochloride Revenue by Application (2017-2028)
9.3 Latin America Pethidine Hydrochloride Market Size by Country
9.3.1 Latin America Pethidine Hydrochloride Sales by Country (2017-2028)
9.3.2 Latin America Pethidine Hydrochloride Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Pethidine Hydrochloride Market Size by Type
10.1.1 Middle East and Africa Pethidine Hydrochloride Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pethidine Hydrochloride Revenue by Type (2017-2028)
10.2 Middle East and Africa Pethidine Hydrochloride Market Size by Application
10.2.1 Middle East and Africa Pethidine Hydrochloride Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pethidine Hydrochloride Revenue by Application (2017-2028)
10.3 Middle East and Africa Pethidine Hydrochloride Market Size by Country
10.3.1 Middle East and Africa Pethidine Hydrochloride Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pethidine Hydrochloride Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Corporation Information
11.1.2 Purdue Pharma Overview
11.1.3 Purdue Pharma Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Purdue Pharma Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Purdue Pharma Recent Developments
11.2 Egalet
11.2.1 Egalet Corporation Information
11.2.2 Egalet Overview
11.2.3 Egalet Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Egalet Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Egalet Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Janssen
11.4.1 Janssen Corporation Information
11.4.2 Janssen Overview
11.4.3 Janssen Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Janssen Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Janssen Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Sun Pharmaceuticals
11.6.1 Sun Pharmaceuticals Corporation Information
11.6.2 Sun Pharmaceuticals Overview
11.6.3 Sun Pharmaceuticals Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sun Pharmaceuticals Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sun Pharmaceuticals Recent Developments
11.7 Mallinckrodt Pharmaceuticals
11.7.1 Mallinckrodt Pharmaceuticals Corporation Information
11.7.2 Mallinckrodt Pharmaceuticals Overview
11.7.3 Mallinckrodt Pharmaceuticals Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mallinckrodt Pharmaceuticals Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mallinckrodt Pharmaceuticals Recent Developments
11.8 Endo Pharmaceuticals
11.8.1 Endo Pharmaceuticals Corporation Information
11.8.2 Endo Pharmaceuticals Overview
11.8.3 Endo Pharmaceuticals Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Endo Pharmaceuticals Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Endo Pharmaceuticals Recent Developments
11.9 Actavis
11.9.1 Actavis Corporation Information
11.9.2 Actavis Overview
11.9.3 Actavis Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Actavis Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Actavis Recent Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Overview
11.10.3 Pfizer Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Recent Developments
11.11 Simson Pharma Limited
11.11.1 Simson Pharma Limited Corporation Information
11.11.2 Simson Pharma Limited Overview
11.11.3 Simson Pharma Limited Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Simson Pharma Limited Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Simson Pharma Limited Recent Developments
11.12 Taj Pharmaceuticals
11.12.1 Taj Pharmaceuticals Corporation Information
11.12.2 Taj Pharmaceuticals Overview
11.12.3 Taj Pharmaceuticals Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Taj Pharmaceuticals Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Taj Pharmaceuticals Recent Developments
11.13 PipelinePharma
11.13.1 PipelinePharma Corporation Information
11.13.2 PipelinePharma Overview
11.13.3 PipelinePharma Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 PipelinePharma Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 PipelinePharma Recent Developments
11.14 Exir Pharmaceutical Company
11.14.1 Exir Pharmaceutical Company Corporation Information
11.14.2 Exir Pharmaceutical Company Overview
11.14.3 Exir Pharmaceutical Company Pethidine Hydrochloride Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Exir Pharmaceutical Company Pethidine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Exir Pharmaceutical Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pethidine Hydrochloride Industry Chain Analysis
12.2 Pethidine Hydrochloride Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pethidine Hydrochloride Production Mode & Process
12.4 Pethidine Hydrochloride Sales and Marketing
12.4.1 Pethidine Hydrochloride Sales Channels
12.4.2 Pethidine Hydrochloride Distributors
12.5 Pethidine Hydrochloride Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pethidine Hydrochloride Industry Trends
13.2 Pethidine Hydrochloride Market Drivers
13.3 Pethidine Hydrochloride Market Challenges
13.4 Pethidine Hydrochloride Market Restraints
14 Key Findings in The Global Pethidine Hydrochloride Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【ペチジン塩酸塩について】 ペチジン塩酸塩は、主にオピオイド系鎮痛薬として使用される医薬品で、特に痛みの管理において重要な役割を果たしています。この薬剤は、1950年代に初めて合成され、その後、医療現場での利用が広まりました。ペチジンは、通常、ペチジン塩酸塩の形で処方され、痛みを軽減するための治療に広く用いられています。 ペチジンは、オピオイド受容体に作用して疼痛信号を抑制することにより、痛みを軽減します。その主なメカニズムは、μ（ミュー）オピオイド受容体に結合することです。この受容体に結合すると、神経伝達物質の放出を抑制し、結果として痛みの知覚が減少します。ペチジンは中枢神経系に作用し、鎮痛効果をもたらしますが、その使用には注意が必要です。 ペチジンにはいくつかの特徴があります。まず、経口、静脈内、筋肉内、皮下など、さまざまな投与方法があり、患者の状態に応じて最適な投与経路を選択することができます。また、ペチジンは急性痛や術後の痛みを管理するためにしばしば使用され、効果が速やかに現れるため、特に多くの医療現場で重宝されています。さらに、ペチジンは他のオピオイド薬と比較して、麻酔作用が比較的短時間であるため、短期間の使用に向いています。 ペチジンの種類には、主にペチジン塩酸塩があり、これが臨床で最も一般的に使用される形態です。ペチジンの製剤は、製造元によって異なる場合がありますが、基本的には同じ成分を持ち、作用機序も同様です。ペチジンの製剤は、通常、錠剤や注射剤の形で提供されます。 ペチジン塩酸塩の主な用途は、急性の中等度から重度の痛みの緩和です。一例として、手術後の痛み管理、外傷による痛み、がんや慢性痛の緩和などがあります。特に、出産時の痛み管理においても利用されることが多く、女性の分娩時の鎮痛において効果的な選択肢の一つとなっています。また、ペチジンは、麻酔科や救急医療の現場でもよく用いられ、緊急時の痛みのコントロールに寄与します。 しかし、ペチジンの使用にはいくつかのリスクが伴います。オピオイドに共通する課題として、依存症のリスクや耐性の形成が挙げられます。長期間の使用は、身体が薬剤に対して依存する可能性があり、突然の中止は離脱症状を引き起こすことがあります。また、ペチジンは副作用も伴い、めまいや眠気、呼吸抑制、消化器系の問題などが報告されています。そのため、医療従事者は、患者の状態を十分に評価し、適切な用量と使用期間を厳守する必要があります。 さらに、ペチジンには相互作用があるため、他の薬剤との併用時には注意が必要です。特に中枢神経系抑制剤やアルコールとの併用は、効果や副作用を増強する可能性があります。このため、患者に対しては使用する薬剤の確認が重要です。 近年、ペチジンを含むオピオイドの使用が問題視されるケースが増えており、オピオイド危機とも呼ばれる状況が生じています。このため、ペチジンの処方は厳格に管理され、必要な時にのみ使用されるべきだという意識が高まっています。患者の痛みの管理を行う中で、代替療法や非ステロイド性抗炎症薬（NSAIDs）など、他の治療選択肢も検討されることが重要です。 ペチジンに関連する技術の発展も注目されています。薬物送達システムや持続投与ポンプの導入により、患者の痛みをより効果的に管理できるようになっています。例えば、持続的な痛みを抱える患者向けに、オピオイドを持続的に投与する方法が開発されています。これにより、急激な痛みの波を抑え、患者のQOL（生活の質）を向上させることが期待されています。 オピオイド療法に対する社会的な関心も高まり、ペチジンを含むオピオイドの利用に際しては、慎重なアプローチが求められます。そのため、医療関係者は最新の知見やガイドラインに基づいた適切な判断を行う必要があります。また、医療従事者が患者に対してオピオイドのリスクや利益を説明し、理解を得ることが重要とされています。 ペチジン塩酸塩は、効果的な鎮痛薬である一方、使用に際しての注意が求められる薬剤です。適切な知識と技術を基に、目的に応じた効果的な痛み管理を行うことが、患者の生活の質を向上させるためには不可欠です。医療界全体として、オピオイドの使用に関する認識を高め、より安全で効果的な治療法の提供に努めていくことが、今後の課題と言えるでしょう。 |